Richard Dean McCormick Periodic Transaction Report

Filed Oct 14, 2026 · House Clerk · 1 transaction

U.S. Representative · R · GA-06 · All trades by Richard Dean McCormick

On October 14, 2026, Rep. Richard Dean McCormick (R-GA-06) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated Sep 18, 2026.

The filing covers 1 ticker, including $BRK.B.

Reported amount ranges sum to $1K–$15K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 26 days.

Source document: House Clerk filing 20035651

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Richard Dean McCormick · Bought $BRK.B · Sep 18 · $1K–$15K

0.34LOW
Disclosure speedx 0.250.30
Trade sizex 0.250.20
Cluster activityx 0.150.30

1 other member traded this name in the same window.

Track recordx 0.350.47

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Richard Dean McCormick

Get an email the moment Richard Dean McCormick files the next one. Free, no card, no spam.

Follow free →
1
Transactions
1 / 0
Buys / sales
1
Tickers
26d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Sep 18, 2026BRK.B
Berkshire Hathaway Inc. New Common Stock (BRK.B)
buy—$1K–$15K26d

Other recent filings by Richard Dean McCormick

← All congressional filings, newest firstFiled Oct 14, 2026October 2026 archive

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →